The built RiskScore with those four factors RBM15B, LRPPRC, IGF2BP1, and IGF2BP3 were likely to divide HCC patients into two prognosis-related clusters and further verified by survival, ROC, UNICOX and MULTICOX analysis in this study. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.